Substance Abuse: Polysubstance Abuse and Addiction

Deadline
Multiple
OPPORTUNITY NO.
PAR-16-291
MECHANISM
R21/R33
RESEARCH AREA(S)
SYNOPSIS

Integrative Research on Polysubstance Abuse and Addiction

This Funding Opportunity Announcement (FOA) is supported by Collaborative Research on Addiction (CRAN) at the National Institutes of Health (NIH), a trans-NIH partnership composed of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), and the National Cancer Institute (NCI). The intent of this FOA is two-fold: (1) characterize how the neurobiological alterations, associated behaviors, and public health consequences arising from polysubstance use differ from, or are similar to, those observed in single drug use; (2) promote integrative polysubstance research along a translational pipeline, consisting of basic science research in animals, human-based laboratory investigations, and epidemiological studies. These dual objectives will be accomplished with a Phased Innovation (R21/R33) mechanism, where polysubstance research can occur in any of these translational stages during the R21 phase and these findings will be rapidly back- or forward-integrated into another stage during the R33 phase, allowing for bi-directional research exchange.

Deadlines:

  • Pre-Application Submission: 30 days before application submission due date
  • Application Submission: 5:00 PM local time of applicant organization, Feb. 16, 2017; Jun. 16, 2017; Oct. 16, 2017; Feb. 16, 2018; Jun. 16, 2018; Oct. 16, 2018; Feb. 16, 2019; Jun. 16, 2019

 

ELIGIBILITY

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.